B7 costimulation in the development of lupus: Autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-B7.1/B7.2 blocking antibodies

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 2322-2329

  Liang, Bailin ^a   Gee, Renelle J ^a   Kashgarian, Michael J ^a   Sharpe, Arlene H ^b   Mamula, Mark J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B7 ANTIGEN; CD86 ANTIGEN; DOUBLE STRANDED DNA; MONOCLONAL ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

EID: 0033566957     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.163.4.2322     Document Type: Article

References (42)

1. Tivol, E. A., A. N. Schweitzer, and A. H. Sharpe. 1996. Costimulation and autoimmunity. Curr. Opin. Immunol. 8:822.
2. Peng, S. L., M. P. Madaio, D. P. M. Hughes, I. N. Crispe, M. J. Owen, L. Wen, A. C. Hayday, and J. Craft. 1996. Murine lupus in the absence of αβ T cells. J. Immunol. 156:4041.
3. + T cells to lymphoproliferation and autoantibody production in MRL lpr/lpr mice. J. Exp. Med. 167:1713.
4. Finck, B., P. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA4Ig. Science 265:1225.
5. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7.1 and B7.2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
6. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7.1 and anti-B7.2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
7. Nakajima, A., M. Azuma, S. Kodera, S. Nuriya, A. Terashi, M. Abe, S. Hirose, T. Shirai, H. Yagita, and K. Okumura. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur. J. Immunol 25:3060.
8. Racke, M. K., D. E. Scott, L. Quigley, G. S. Gray, R. Abe, C. H. June, and P. J. Perrin. 1995. Distinct roles for B7.1 and B7.2 in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96:2195.
9. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7.1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
10. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller, and J. A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783.
11. Freeman, G. J., F. Borriello, R. J. Hodes, H. Reiser, K. S. Hathcock, G. Laszlo, A. J. McKnight, J. Kim, L. Du, D. B. Lombard, G. S. Gray, L. M. Nadler, and A. H. Sharp. 1993. Uncovering of functional alternative CTLA4 counter-receptor in B7-deficient mice. Science 262:907.
12. Bringmann, P., J. Rinke, B. Appel, R. Reuter, and R. Luhrmann. 1983. Purification of snRNPs U1, U2, U4, U5, and U6 with 2,2,7-trimethylguanosine-specific antibody and definition of their constituent proteins reacting with anti-Sm and anti-(U1)RNP antisera. EMBO J. 2:1129.
13. Kashgarian, M. 1997. Lupus nephritis: pathology, pathogenesis, clinical correlations, and prognosis. In Dubois' Lupus Erythematosus, 5th Ed. D. J. Wallace and B. H. Hahn, eds. Williams and Wilkins, Baltimore, pp. 1037-1052.
14. Borriello, F., M. P. Sethna, S. D. Boyd, A. Nicola Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson. G. J. Freeman, and A. H. Sharpe. 1997. B7.1 and B7.2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303.
15. Chan, O., and M. J. Shlomchik. 1998. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL lpr/lpr mice. J. Immunol. 160:51.
16. Steinberg, A. D. 1994. MRL lpr/lpr disease: theories meet Fas. Semin. Immunol. 6:55.
17. Mamula, M. J. 1995. Lupus autoimmunity: from peptides to particles. Immunol. Rev. 144:301.
18. Peng, S. L., and J. Craft. 1996. T cells in murine lupus: propagation and regulation of disease. Mol. Biol. Rep. 23:247.
19. Steinberg, A. D., J. B. Roths, E. D. Murphy, R. T. Steinberg, and E. S. Raveche. 1980. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J. Immunol. 125:871.
20. Sobel, E. S., P. L. Cohen, and R. A. Eisenberg. 1993. Lpr T cells are necessary for autoantibody production in lpr mice. J. Immunol. 150:4160.
21. Seaman, W. E., D. Wofsy, J. S. Greenspan, and J. A. Ledbetter. 1983. Treatment of autoimmune MRL/lpr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease. J. Immunol 130:1713.
22. 1 mice by treatment with monoclonal antibody to L3T4. J. Immunol. 138:3247.
23. Adams, S., P. Leblanc, and S. K. Datta. 1991. Junctional region sequences of T-cell receptor β-chain genes expressed by pathogenic anti-DNA autoantibody-inducing helper T cells from lupus mice: possible selection by cationic autoantigens. Proc. Natl. Acad. Sci. USA 88:11271.
24. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367.
25. Jevnikar, A. M., M. J. Grusby, and L. H. Glimcher. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179:1137.
26. Koh, D. R., A. Ho, A. Rahemtulla, W. P. Fung-Leung, H. Griesser, and T. W. Mak. 1995. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur. J. Immunol. 25:2558.
27. Adams, S., T. Zordan, K. Sainis, and S. Datta. 1990. T cell receptor V β genes expressed by IgG anti-DNA autoantibody-inducing T cells in lupus nephritis: forbidden receptors and double-negative T cells. Eur. J. Immunol. 20:1435.
28. Singh, R. R., V. Kumar, F. B. Ebling, S. Southwood, A. Sette, E. E. Sercarz, and B. H. Hahn. 1995. T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 181: 2017.
29. + and abnormal lpr and gld cell populations. J. Exp. Med. 170:1869.
30. Herron, L. R., R. A. Eisenberg, E. Roper, V. N. Kakkanaiah, P. L. Cohen, and B. L. Kotzin. 1993. Selection of the T cell receptor repertoire in lpr mice. J. Immunol. 151:3450.
31. Schweitzer, A. N., F. Borriello, R. C. K. Wong, A. K. Abbas, and A. H. Sharpe. 1997. Role of costimulators in T cell differentiation. J. Immunol. 158:2713.
32. Peng, S. L., J. M. McNiff, M. P. Madaio, J. Ma, M. J. Owen, R. A. Flavell, A. C. Hayday, and J. Craft. 1997. αβ T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J. Immunol. 158:2464.
33. Daikh, D. I., B. K. Finck, P. S. Linsley, D. Hollenbaugh, and D. Wofsy. 1997. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/ CD28 and CD40/gp39 costimulation pathways. J. Immunol. 159:3104.
34. Hutloff, A., A. M. Dittrich, K. C. Beier, B. Eljaschewitsch, R. Kraft, I. Anagnostopoulos, and R. A. Kroczek. 1999. ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 397:263.
35. Man, S., K. Hathcock, B. Zheng, T. B. Kepler, R. Hodes, and G. Kelsoe. 1995. Cellular interaction in germinal centers: roles of CD40 ligand and B7.2 in established germinal centers. J. Immunol. 155:556.
36. Judge, T. A., Z. Wu, X. G. Zheng, A. H. Sharpe, M. H. Sayegh, and L. A. Turka. 1999. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J. Immunol. 162:1947.
37. Peterson, K. E., G. C. Sharp, H. Tang, and H. Braley-Mullen. 1999. B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis. J. Immunol. 162:1859.
38. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell cosumulatory requirements in CD28-deficient mice. Science 261:609.
39. Kundig, T. M., A. Shahinian, K. Kawai, H. W. Mittrucker, E. Sebzda, M. F. Bachmann, T. W. Mak, and P. S. Ohashi. 1996. Duration of TCR stimulation determines costimulatory requirements. Immunity 5:41.
40. Brown, D. R., J. M. Green, N. H. Moskowitz, M. Davis, C. B. Thompson, and S. L. Reiner. 1996. Limited role of CD28-mediated signals in T helper subset differentiation. J. Exp. Med. 184:803.
41. Shahinian, A., K. Pfeffer, K. P. Lee. T. M. Kundig, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28 deficient mice. Science 261:609.
42. Bachmann, M. F., K. McKall-Faienza, R. Schmits, D. Bouchard, J. Beach, D. E. Speiser T. W. Mak, and P. S. Ohashi. 1997. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 7:549.